Novel tetrahydropyran-based peptidomimetics from a bioisosteric transformation of a tripeptide. Evidence of their activity at melanocortin receptors

被引：12

作者：

Mazur, AW ^{[1
]}

Kulesza, A ^{[1
]}

Mishra, RK ^{[1
]}

Cross-Doersen, D ^{[1
]}

Russell, AF ^{[1
]}

Ebetino, FH ^{[1
]}

机构：

[1] Procter & Gamble Pharmaceut, Hlth Care Res Ctr, Mason, OH 45040 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2003年 / 11卷 / 14期

关键词：

D O I：

10.1016/S0968-0896(03)00274-8

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

We have prepared novel peptidomimetics based on a 2,4,6-trisubstituted tetrahydropyran. This scaffold was constructed in an isosteric transformation using conceptual constraints imposed on a tripeptide moiety involving O-i'-C-1(+1)gamma and O-i'-Ni+2 formal cyclization modes. A series of regioselective transformations commencing with a substituted dihydropyran-4-one readily provided the required analogues. Specific tetrahydropyrane analogues modeled on PheArgTrp as a truncated version of the melanocortin receptor message sequence, showed activity at the melanocortin receptors MC4R and MC1R. Thus, the 2,4,6-trisubstituted tetrahydropyran scaffold has provided a potentially useful peptidomimetic lead, and conceptual cyclization of peptide moieties can offer a valuable design strategy in peptidomimetic research. (C) 2003 Elsevier Science Ltd. All rights reserved.

引用

页码：3053 / 3063

页数：11

共 34 条

[11] Homologs of 1,2,5-hexahydro-3-one-1H-1,4-diazepine (DAP) as novel dipeptidomimetics and molecular scaffolds:: Efficient preparation of synthons
Han, YL
Mierke, DF
Chorev, M
[J]. BIOPOLYMERS, 2002, 64 (01) : 1 - 15
[12] Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R
HaskellLuevano, C
Hendrata, S
North, C
Sawyer, TK
Hadley, ME
Hruby, VJ
Dickinson, C
Gantz, I
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (14) : 2133 - 2139
[13] NONPEPTIDAL PEPTIDOMIMETICS WITH A BETA-D-GLUCOSE SCAFFOLDING - A PARTIAL SOMATOSTATIN AGONIST BEARING A CLOSE STRUCTURAL RELATIONSHIP TO A POTENT, SELECTIVE SUBSTANCE-P ANTAGONIST
HIRSCHMANN, R
NICOLAOU, KC
PIETRANICO, S
SALVINO, J
LEAHY, EM
SPRENGELER, PA
FURST, G
SMITH, AB
STRADER, CD
CASCIERI, MA
CANDELORE, MR
DONALDSON, C
VALE, W
MAECHLER, L
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1992, 114 (23) : 9217 - 9218
[14] Structure-activity relationships of the melanocortin tetrapeptide Ac-His-D-Phe-Arg-Trp-NH2 at the mouse melanocortin receptors.: 4.: Modifications at the Trp position
Holder, JR
Xiang, ZM
Bauzo, RM
Haskell-Leuvano, C
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (26) : 5736 - 5744
[15] Conformational and topographical considerations in designing agonist peptidomimetics from peptide leads
Hruby, VJ
Balse, PM
[J]. CURRENT MEDICINAL CHEMISTRY, 2000, 7 (09) : 945 - 970
[16] HUDLICKY M, 1996, ACS MONOGR SER, V188, P298
[17] IMPROVED METHOD FOR THE PREPARATION OF GUANIDINES
KIM, KS
QIAN, LG
[J]. TETRAHEDRON LETTERS, 1993, 34 (48) : 7677 - 7680
[18] SYNTHESIS OF HYDROXYETHYLENE ISOSTERES OF THE TRANSITION-STATE OF THE HIV PROTEASE-CATALYZED PHE-PRO HYDROLYSIS - REACTION OF 2-[(BOC)AMINO]-1-(2'-OXOCYCLOPENTYL)-3-PHENYLPROPANOLS WITH DIETHYL PHOSPHOROCYANIDATE AND LITHIUM CYANIDE FOLLOWED BY SAMARIUM IODIDE
KONIECZNY, MT
TOMA, PH
CUSHMAN, M
[J]. JOURNAL OF ORGANIC CHEMISTRY, 1993, 58 (17) : 4619 - 4624
[19] Le Merrer Y, 1999, METH MOLEC MED, V23, P227, DOI 10.1385/0-89603-517-4:227
[20] Lohof E, 1999, ADV AMIN AC MIM PEPT, V2, P263, DOI 10.1016/S1874-5113(99)80011-2

← 1 2 3 4 →